Spyre Therapeutics, Inc. (SYRE) Technical Analysis & Indicators
Spyre Therapeutics, Inc. (SYRE) — Price $99.27 (closing price, November 3, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Spyre Therapeutics, Inc. (SYRE): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Spyre Therapeutics, Inc. is a biotechnology firm operating at the preclinical stage, dedicated to creating innovative treatments for individuals afflicted with inflammatory bowel disease (IBD). Among its pipeline candidates is SPY001, a human monoclonal immunoglobulin G1 antibody specifically engineered to target and bind with the a4ß7 integrin. This particular therapy is under development for addressing both ulcerative colitis and Crohn's disease, two forms of IBD.